Sheaff Brock Investment Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,300
| Closed | -$225K | – | 461 |
|
|
2024
Q3 | $225K | Buy |
+3,300
| New | +$186K | 0.02% | 375 |
|
|
2024
Q2 | – | Sell |
-3,635
| Closed | -$251K | – | 481 |
|
|
2024
Q1 | $251K | Sell |
3,635
-100
| -3% | -$6.33K | 0.02% | 392 |
|
|
2023
Q4 | $276K | Hold |
3,735
| – | – | 0.02% | 360 |
|
|
2023
Q3 | $255K | Buy |
3,735
+100
| +3% | +$8.48K | 0.02% | 359 |
|
|
2023
Q2 | $341K | Hold |
3,635
| – | – | 0.03% | 324 |
|
|
2023
Q1 | $246K | Buy |
+3,635
| New | +$234K | 0.02% | 394 |
|
|
2022
Q2 | – | Sell |
-3,535
| Closed | -$247K | – | 518 |
|
|
2022
Q1 | $247K | Hold |
3,535
| – | – | 0.02% | 418 |
|
|
2021
Q4 | $275K | Hold |
3,535
| – | – | 0.02% | 407 |
|
|
2021
Q3 | $337K | Hold |
3,535
| – | – | 0.02% | 343 |
|
|
2021
Q2 | $440K | Hold |
3,535
| – | – | 0.03% | 289 |
|
|
2021
Q1 | $466K | Hold |
3,535
| – | – | 0.04% | 264 |
|
|
2020
Q4 | $468K | Sell |
3,535
-3,000
| -46% | -$363K | 0.04% | 250 |
|
|
2020
Q3 | $666K | Sell |
6,535
-550
| -8% | -$47.5K | 0.06% | 187 |
|
|
2020
Q2 | $616K | Buy |
7,085
+50
| +0.7% | +$4K | 0.06% | 196 |
|
|
2020
Q1 | $408K | Sell |
7,035
-100
| -1% | -$8.12K | 0.05% | 210 |
|
|
2019
Q4 | $660K | Buy |
7,135
+235
| +3% | +$20.7K | 0.06% | 203 |
|
|
2019
Q3 | $624K | Buy |
6,900
+125
| +2% | +$14.2K | 0.07% | 206 |
|
|
2019
Q2 | $800K | Hold |
6,775
| – | – | 0.09% | 173 |
|
|
2019
Q1 | $587K | Sell |
6,775
-625
| -8% | -$53.2K | 0.07% | 227 |
|
|
2018
Q4 | $467K | Hold |
7,400
| – | – | 0.07% | 236 |
|
|
2018
Q3 | $584K | Hold |
7,400
| – | – | 0.06% | 240 |
|
|
2018
Q2 | $442K | Hold |
7,400
| – | – | 0.04% | 285 |
|
|
2018
Q1 | $298K | Sell |
7,400
-300
| -4% | -$14.6K | 0.03% | 357 |
|
|
2017
Q4 | $405K | Sell |
7,700
-1,000
| -11% | -$53.4K | 0.05% | 290 |
|
|
2017
Q3 | $410K | Sell |
8,700
-2,100
| -19% | -$84.5K | 0.05% | 294 |
|
|
2017
Q2 | $382K | Sell |
10,800
-3,400
| -24% | -$105K | 0.05% | 334 |
|
|
2017
Q1 | $335K | Buy |
14,200
+3,900
| +38% | +$77.3K | 0.04% | 368 |
|
|
2016
Q4 | $138K | Hold |
10,300
| – | – | 0.02% | 549 |
|
|
2016
Q3 | $191K | Hold |
10,300
| – | – | 0.03% | 478 |
|
|
2016
Q2 | $126K | Sell |
10,300
-2,500
| -20% | -$18.8K | 0.02% | 528 |
|
|
2016
Q1 | $86K | Buy |
12,800
+2,500
| +24% | +$16K | 0.01% | 563 |
|
|
2015
Q4 | $95K | Buy |
+10,300
| New | +$95.8K | 0.01% | 587 |
|
Other funds holding EXAS
Sheaff Brock Investment Advisors's EXAS Position: Q4 2024 in Review
Sheaff Brock Investment Advisors sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 3,300 shares — an estimated $225K sold.
Sheaff Brock Investment Advisors first reported a position in EXAS in Q4 2015 and held it in 32 quarters. The position peaked at $800K in Q2 2019. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.
- Sheaff Brock Investment Advisors reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
- Sheaff Brock Investment Advisors sold 3,300 Exact Sciences shares in Q4 2024, an estimated $225K.
- Sheaff Brock Investment Advisors first reported a position in Exact Sciences in Q4 2015 and held it in 32 quarters.
- Sheaff Brock Investment Advisors's Exact Sciences position peaked at $800K in Q2 2019.
- 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.
Based on Sheaff Brock Investment Advisors's 13F filing for Q4 2024, filed 30 Jan 2025.